Technical Analysis for AYTU - Aytu BioScience, Inc.

Grade Last Price % Change Price Change
grade F 0.59 -3.28% -0.02
AYTU closed down 3.28 percent on Friday, April 20, 2018, on approximately normal volume.

Earnings due: May 10

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent N/A Down Up
See historical AYTU trend table...

Date Alert Name Type % Chg
Apr 20 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Apr 20 Wide Bands Range Expansion 0.00%
Apr 19 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -3.28%
Apr 19 Weak + Overbought Other -3.28%
Apr 19 Outside Day Range Expansion -3.28%
Apr 19 Wide Bands Range Expansion -3.28%
Apr 19 Overbought Stochastic Strength -3.28%
Apr 19 Up 3 Days in a Row Strength -3.28%
Apr 18 Narrow Range Bar Range Contraction 11.32%
Apr 18 Inside Day Range Contraction 11.32%

Older signals for AYTU ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Aytu BioScience, Inc. is a commercial-stage healthcare company focused on acquiring, developing and commercializing products in the field of urology. The Company focuses on hypogonadism, prostate cancer, urinary tract infections and male infertility. The Company markets ProstaScint (capromab pendetide), a radio imaging agent indicated to detect the prostate specific membrane antigen (PSMA) in the assessment and staging of prostate cancer. The Company's pipeline includes MiOXSYS, an in vitro diagnostic device. MiOXSYS system is a point-of-care semen analysis system, used for diagnosis and management of male infertility. The Company holds the United States rights to Natesto (testosterone), a formulation of testosterone delivered through a nasal gel. Natesto is used for the treatment of hypogonadism (low testosterone) in men. The Company, through its wholly-owned subsidiary Nuelle, Inc., is focused on women’s sexual wellbeing and intimacy.
Is AYTU a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 2 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.82
52 Week Low 0.38
Average Volume 3,036,002
200-Day Moving Average 0.0
50-Day Moving Average 0.7219
20-Day Moving Average 0.5698
10-Day Moving Average 0.5636
Average True Range 0.089
ADX 8.78
+DI 28.23
-DI 21.77
Chandelier Exit (Long, 3 ATRs ) 0.493
Chandelier Exit (Short, 3 ATRs ) 0.6788
Upper Bollinger Band 0.6846
Lower Bollinger Band 0.455
Percent B (%b) 0.59
BandWidth 40.29484
MACD Line -0.0585
MACD Signal Line -0.0903
MACD Histogram 0.0317
Fundamentals Value
Market Cap 2.37 Million
Num Shares 4.02 Million
EPS -48.30
Price-to-Earnings (P/E) Ratio -0.01
Price-to-Sales 4.58
Price-to-Book 0.76
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.68
Resistance 3 (R3) 0.68 0.66 0.67
Resistance 2 (R2) 0.66 0.63 0.66 0.66
Resistance 1 (R1) 0.62 0.62 0.61 0.62 0.65
Pivot Point 0.60 0.60 0.59 0.60 0.60
Support 1 (S1) 0.56 0.57 0.55 0.56 0.53
Support 2 (S2) 0.54 0.56 0.54 0.52
Support 3 (S3) 0.50 0.54 0.52
Support 4 (S4) 0.50